Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection

PURPOSE: Ceftazidime/avibactam (CAZ/AVI) monotherapy and polymyxin B-based combination therapy are currently two treatment options for patients with carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection; however, few studies have contrasted the relative efficacy of the two antibiotic regimens...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Juan, Liang, Qiqiang, Chen, Xinyi, Wu, Jing, Wu, Yanchao, Teng, Gaoqin, Huang, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887910/
https://www.ncbi.nlm.nih.gov/pubmed/35241917
http://dx.doi.org/10.2147/IDR.S350976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887910/
https://www.ncbi.nlm.nih.gov/pubmed/35241917
http://dx.doi.org/10.2147/IDR.S350976

Ejemplares similares